The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

NCT05486468 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Uveitis
Uveitis, Posterior
Uveitis, Anterior
Uveitis, Intermediate

Interventions

DRUG: Yutiq 0.18 MG Drug Implant
OTHER: Sham Injection

Sponsor

Texas Retina Associates

Collaborators

[object Object]
[object Object]